Abstract

Ebfs are a family of transcription factors regulating the differentiation of multiple cell types of mesenchymal origin, including osteoblasts. Global deletion of Ebf1 results in increased bone formation and bone mass, while global loss of Ebf2 leads to enhanced bone resorption and decreased bone mass. Targeted deletion of Ebf1 in early committed osteoblasts leads to increased bone formation, whereas deletion in mature osteoblasts has no effect. To study the effects of Ebf2 specifically on long bone development, we created a limb bud mesenchyme targeted Ebf2 knockout mouse model by using paired related homeobox gene 1 (Prrx1) Cre. To investigate the possible interplay between Ebf1 and Ebf2, we deleted both Ebf1 and Ebf2 in the cells expressing Prrx1. Mice with Prrx1-targeted deletion of Ebf2 had a very mild bone phenotype. However, deletion of both Ebf1 and Ebf2 in mesenchymal lineage cells lead to significant, age progressive increase in bone volume. The phenotype was to some extent gender dependent, leading to an increase in both trabecular and cortical bone in females, while in males a mild cortical bone phenotype and a growth plate defect was observed. The phenotype was observed at both 6 and 12 weeks of age, but it was more pronounced in older female mice. Our data suggest that Ebfs modulate bone homeostasis and they are likely able to compensate for the lack of each other. The roles of Ebfs in bone formation appear to be complex and affected by multiple factors, such as age and gender.

Highlights

  • B-cell factors (Ebfs) are a four‐member family of transcription factors (Ebf1-Ebf4) that regulate the differentiation of e.g. neuronal cells [1, 2], B-cells [3, 4] and adipocytes [5, 6]

  • Global Deletion of Ebf2 Leads to Impaired Bone Formation

  • As the global deletion of Ebf2 leads to progressive developmental defects [2], the mice were analysed at three weeks of age to minimize the suffering of the animals

Read more

Summary

Introduction

B-cell factors (Ebfs) are a four‐member family of transcription factors (Ebf1-Ebf4) that regulate the differentiation of e.g. neuronal cells [1, 2], B-cells [3, 4] and adipocytes [5, 6]. Zee et al reported that targeting Ebf deletion to osteoblast lineage using Runx2-Cre had no effect on osteoblast differentiation or bone accrual [12]. Seike et al observed that targeting Ebf deletion to early limb bud mesenchyme with paired related homeobox gene 1 (Prrx1) did not lead to detectable bone abnormalities [9]. Derecka et al reported that Prrx1-driven deletion of Ebf leads to increased bone formation [10]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call